Rongguo Li
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Axitinib promotes stemness and vasculogenic mimicry in triple-negative breast cancer by disrupting THBS1-CD47 axis-mediated endothelial-tumor cell communication.
Journal: Apoptosis : an international journal on programmed cell death
Published: March 13, 2026
Reevaluating sentinel lymph node biopsy in older adults with T1 HR+/HER2- breast cancer: a SEER competing risk and nomogram study.
Journal: Breast cancer (Tokyo, Japan)
Published: February 12, 2026
Suspected track-site seeding as an isolated deep SH-SCM papillary thyroid carcinoma lesion years after TOETVA.
Journal: European thyroid journal
Published: December 05, 2025
Defining the ATA-2025 'consider RAIT' zone in older patients with N1b PTC.
Journal: Endocrine-related cancer
Published: October 15, 2025
Tenascin C Enhances the Development of Papillary Thyroid Carcinoma and has Diagnostic Significance in Papillary Thyroid Microcarcinoma.
Journal: The Tohoku journal of experimental medicine
Published: March 26, 2025
Unraveling the role of adjuvant chemotherapy in elderly triple-negative breast cancer: Insights from competing risk analysis using SEER data.
Journal: Cancer epidemiology
Published: February 28, 2025
Bilateral Thyroid Ima Arteries Arising From the Brachiocephalic Trunk: A First Case Report.
Journal: Head & neck
Published: January 28, 2025
miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin.
Journal: Anti-cancer drugs
Published: December 20, 2021
Circular RNA circZFR contributes to papillary thyroid cancer cell proliferation and invasion by sponging miR-1261 and facilitating C8orf4 expression.
Journal: Biochemical and biophysical research communications
Published: May 09, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026